Skip to main content

Table 1 List of cancer datasets used in this analysis

From: E2F4 regulatory program predicts patient survival prognosis in breast cancer

GSE ID

Platform

Cancer type

Number of samples

Source

-

cDNA two channel

Breast

295

Vijver et al., 2002 [4]

GSE1456

HG-U133A

Breast

159

Pawitan et al., 2005 [8]

GSE2034

HG-U133A

Breast

286

Wang et al., 2005 [5]

GSE2990

HG-U133A

Breast

177

Sotiriou et al., 2006 [6]

GSE3494

HG-U133A

Breast

260

Miller et al., 2005 [7]

GSE6532

HG-U133A

Breast

327

Loi et al., 2008 [33]

GSE7390

HG-U133A

Breast

198

Desmedt et al., 2007 [34]

GSE11121

HG-U133A

Breast

200

Schmidt et al., 2008 [35]

GSE13507

Illumina beadchip

Bladder

256

Kim et al., 2010 [36]

GSE13041

HG-U133A

Glioblastoma

191

Lee et al., 2008 [37]

GSE8894

HG-U133 Plus 2

Non-small cell lung

138

Lee et al., 2008 [38]

GSE17536

HG-U133 Plus 2

Colon

177

Smith et al., 2010 [39]

GSE425

cDNA two channel

Acute myeloid leukemia

119

Bullinger et al., 2004 [40]

GSE4475

HG-U133A

Burkitt’s lymphoma

221

Hummel et al., 2006 [41]